Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.370
+0.120 (3.69%)
Nov 22, 2024, 4:00 PM EST - Market closed
Atea Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -174.01 | -135.96 | -115.91 | 121.19 | -10.95 | -14.03 | |
| Depreciation & Amortization | 0.42 | 0.42 | 0.26 | 0.03 | 0.02 | 0.02 | |
| Loss (Gain) From Sale of Investments | -13.45 | -15.45 | -5.47 | - | - | - | |
| Stock-Based Compensation | 49.63 | 49.43 | 46.72 | 39.62 | 7.46 | 0.62 | |
| Change in Accounts Receivable | - | - | - | - | -5.82 | - | |
| Change in Accounts Payable | 5.39 | 1.7 | -1.98 | 10.29 | -0.49 | 0.16 | |
| Change in Unearned Revenue | - | - | - | -301.37 | 301.37 | - | |
| Change in Other Net Operating Assets | 5.09 | 14.46 | -44.6 | 43.23 | 5.14 | 0.41 | |
| Operating Cash Flow | -126.94 | -85.4 | -120.98 | -87.01 | 296.73 | -12.83 | |
| Capital Expenditures | - | - | -1.94 | -0 | -0.03 | -0 | |
| Investment in Securities | 87.25 | 40.3 | -453.47 | - | - | - | |
| Investing Cash Flow | 87.25 | 40.3 | -455.41 | -0 | -0.03 | -0 | |
| Issuance of Common Stock | 0.27 | 0.26 | 0.37 | 1.47 | 317.63 | - | |
| Other Financing Activities | - | - | - | - | -0.02 | - | |
| Financing Cash Flow | 0.27 | 0.26 | 0.37 | 1.47 | 531.75 | - | |
| Net Cash Flow | -39.42 | -44.84 | -576.02 | -85.54 | 828.46 | -12.83 | |
| Free Cash Flow | -126.94 | -85.4 | -122.93 | -87.01 | 296.71 | -12.83 | |
| Free Cash Flow Margin | - | - | - | -24.76% | 610.10% | - | |
| Free Cash Flow Per Share | -1.51 | -1.02 | -1.48 | -0.99 | 13.74 | -1.27 | |
| Levered Free Cash Flow | -17.91 | -9.44 | -69.52 | -127.65 | 300.81 | -7.86 | |
| Unlevered Free Cash Flow | -17.91 | -9.44 | -69.52 | -127.65 | 300.81 | -7.86 | |
| Change in Net Working Capital | -10.35 | -15.72 | 45.11 | 253.78 | -300.25 | -0.63 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.